Stocks and Investing Stocks and Investing
Fri, August 7, 2020

Chris Howerton Downgraded (TXMD) to Sell and Decreased Target to $60 on, Aug 7th, 2020


Published on 2024-10-27 11:49:13 - WOPRAI, Chris Howerton
  Print publication without navigation


Chris Howerton of Jefferies, Downgraded "TherapeuticsMD, Inc." (TXMD) to Sell and Decreased Target from $63 to $60 on, Aug 7th, 2020.

Chris has made no other calls on TXMD in the last 4 months.



There are 3 other peers that have a rating on TXMD. Out of the 3 peers that are also analyzing TXMD, 1 agrees with Chris's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Chris Schott of "JP Morgan" Downgraded from Buy to Hold on, Tuesday, May 19th, 2020


These are the ratings of the 2 analyists that currently disagree with Chris


  • Douglas Tsao of "HC Wainwright & Co." Reiterated at Strong Buy with Decreased Target to $250 on, Thursday, May 7th, 2020
  • Annabel Samimy of "Stifel" Maintained at Strong Buy with Increased Target to $750 on, Thursday, April 16th, 2020
Contributing Sources